Processa Pharmaceuticals, Inc. (PCSA) Press Releases https://www.processapharmaceuticals.com/news-media-removed-14fb2802/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/processapharmaceuticals/files/theme/images/logo-sm.png Processa Pharmaceuticals, Inc. Logo https://www.processapharmaceuticals.com Equisolve Investor Relations Suite <![CDATA[Processa Pharmaceuticals to Participate in Upcoming Investor Conferences]]> https://www.processapharmaceuticals.com/news-media-removed-14fb2802/press-releases/detail/146/processa-pharmaceuticals-to-participate-in-upcoming Tue, 01 Sep 26 07:00:00 -0400 https://www.processapharmaceuticals.com/news-media-removed-14fb2802/press-releases/detail/146/processa-pharmaceuticals-to-participate-in-upcoming <![CDATA[PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS]]> https://www.processapharmaceuticals.com/news-media-removed-14fb2802/press-releases/detail/145/processa-pharmaceuticals-inc-announces-acquisition-of Wed, 29 Jul 26 07:30:00 -0400 https://www.processapharmaceuticals.com/news-media-removed-14fb2802/press-releases/detail/145/processa-pharmaceuticals-inc-announces-acquisition-of